Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Circulatory

  • 1
    News

    Andexanet alfa effectively reverses factor Xa inhibition

    March 18, 2019

    HONOLULU – The drug establishes good or excellent hemostasis in 82% of patients with acute major bleeding associated with factor Xa inhibition.

  • 1
    News

    Supplementary compression doesn’t improve DVT odds in critically ill

    February 20, 2019

    SAN DIEGO – The procedure carries few risks, aside from patient discomfort.

  • 1
    News

    PERT alerts improve pulmonary embolism outcomes

    February 20, 2019

    SAN DIEGO – Alerts that prompt multidisciplinary consultations cut death rates, ICU times in pulmonary embolism patients.

  • 1
    News

    When is it safe to resume anticoagulation in my patient with hemorrhagic stroke?

    February 5, 2019

    Robust scientific data on when to resume anticoagulation after ICH does not exist.

  • 1
    News

    COPD linked to higher in-hospital death rates in patients with PAD

    January 22, 2019

    COPD was an independent predictor of in-hospital death and of pulmonary embolism in PAD patients.

  • 1
    News

    CTPA may not rule out VTE in high-risk patients

    January 21, 2019

    Does a negative computed tomography pulmonary angiography rule out venous thromboembolism (VTE)?

  • 1
    News

    VTE prophylaxis often overused in low-risk patients

    January 14, 2019

    Is venous thromboembolism (VTE) prophylaxis being appropriately prescribed in hospitalized patients?

  • 1
    Video

    ARISTOPHANES: Apixaban edges other DOACS for octogenarians 

    December 2, 2018

    CHICAGO – Insurance claims data from more than 50,000 U.S. octogenarians on a DOAC showed apixaban worked best and caused the fewest major bleeds.

  • 1
    News

    ASH releases new VTE guidelines

    November 28, 2018

    A panel of the American Society of Hematology released more than 150 recommendations for dealing with venous thromboembolism.

  • News

    All patients with VTE have a high risk of recurrence

    November 20, 2018

    Researchers suggest rethinking categorization of patients with incident venous thromboembolism.

Previous1 … 11 12 13 14 15 … 25Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences